INCY
NASDAQ · Biotechnology
Incyte Corp
$104.40
+0.74 (+0.71%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.29%
1Y
+51.28%
YTD
+2.94%
Open$104.61
Previous Close$103.66
Day High$105.48
Day Low$103.07
52W High$112.29
52W Low$66.74
Volume—
Avg Volume2.45M
Market Cap19.62B
P/E Ratio13.71
EPS$7.07
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$101.74
Above
SMA 200
$86.15
Above
RSI (14)
51.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
35 analysts
Price Target
+98.1% upside
Current
$104.40
$104.40
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.12B | 4.46B | 3.83B |
| Net Income | 1.28B | 1.00B | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.53B | 1.27B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |